Genbin Shi

Title: Genbin Shi: Innovator in Antibacterial Agents

Introduction

Genbin Shi is a prominent inventor based in Frederick, MD (US). He has made significant contributions to the field of antibacterial agents, holding a total of 3 patents. His work focuses on developing novel compounds that target essential processes in bacterial biosynthesis.

Latest Patents

Genbin Shi's latest patents include innovative HPPK inhibitors that are useful as antibacterial agents. The first patent discloses linked purine pterin compounds of Formula I, which are novel inhibitors of HPPK, a kinase responsible for an essential step in the biosynthesis of folic acid. These compounds bind to HPPK with high affinity and specificity, providing a promising avenue for treating bacterial infections. The second patent also describes linked purine pterin compounds and their analogs as HPPK inhibitors, emphasizing their pharmaceutical applications and methods for treating bacterial infections.

Career Highlights

Genbin Shi works for the United States of America, as Represented by the Secretary, Department of Health and Human Services. His research has led to the development of pharmaceutical compositions that incorporate HPPK inhibitors, showcasing his commitment to advancing medical science.

Collaborations

Some of his notable coworkers include Xinhua Ji and Gary X Shaw, who have collaborated with him on various projects related to antibacterial agents.

Conclusion

Genbin Shi's innovative work in developing HPPK inhibitors highlights his significant contributions to the field of antibacterial research. His patents reflect a dedication to improving treatment options for bacterial infections, making a lasting impact in the medical community.